Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Using shockwave therapy to treat breast reconstruction fibrosis

Official title: A Prospective Single-center Study for Evaluation of the Effectiveness of Pulsed Acoustic Cellular Expression Technology on Post-Operative Soft Tissue Fibrosis.

Run by Northwestern University · NCT06919042 · Data updated 2026-11-12

This study tests whether shockwave therapy can help women with breast reconstruction reduce scarring and improve their recovery after surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment100 (estimated)
SponsorNorthwestern University
Academic / other
Drugs / interventionsradiation
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedMay 2026
Study endsSeptember 2026
Registry record updatedApril 16, 2026
Trial IDNCT06919042 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult females who have developed postoperative fibrosis following breast reconstruction surgery.

Probably not a fit

Patients with active infections, systemic illnesses, or those who are pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of extracorporeal shockwave therapy in reducing postoperative soft tissue fibrosis in women who have undergone breast reconstruction. It is a single-blind, randomized controlled trial where participants receive either active shockwave therapy or a sham treatment over eight sessions within four weeks. Follow-up evaluations are conducted three months post-treatment to assess outcomes. The study includes adult females with clinically diagnosed postoperative fibrosis and excludes those with certain medical conditions or prior treatments that may interfere with results.

Why it matters

Potential benefit: If successful, this therapy could significantly improve the quality of life for patients suffering from postoperative breast reconstruction fibrosis.

How similar studies have gone: While this approach is relatively novel, similar studies using shockwave therapy for other types of fibrosis have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects greater than 18 years of age.
* Subjects who have undergone plastic surgery procedures and present in the post-operative period with soft tissue firmness suggestive of subcutaneous/parenchymal fibrosis.

Exclusion Criteria:

* Subjects with cardiac pacemakers
* Other medical or psychiatric condition that may increase the risk associated with study participation, may complicate subject compliance, or may interfere with the interpretation of study results and, in the judgment of the Investigator, would make the subject inappropriate for entry into this study.
* Proximity of fibrotic tissue directly adjacent to bone
* Face/neck areas are excluded
* Patients who, in the opinion of the investigator, would not be compliant with the schedule of study visits

Where it's running

  • Lavin Pavilion Suite 2060
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.